This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox 1666
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
Since Beta-Lactam antibiotics are used very often in antimicrobial therapy to treat bacterial infections, bacterial resistance often ocurrs. This enzyme, CTX-M Beta-Lactamase, inhibits the drug's function by breaking apart the lactam ring, making it harder to treat. This is a problem because if we can understand it better, we can change the way we treat to fight off the bacteria better. | Since Beta-Lactam antibiotics are used very often in antimicrobial therapy to treat bacterial infections, bacterial resistance often ocurrs. This enzyme, CTX-M Beta-Lactamase, inhibits the drug's function by breaking apart the lactam ring, making it harder to treat. This is a problem because if we can understand it better, we can change the way we treat to fight off the bacteria better. | ||
| + | There have been several inhibitor-resistant variants that mutations have risen from. More specifically one of them being K234R. This mutation causes a 1500-fold decrease in the cefotaxime and a 5-fold increase in the Kcat for ampicillin. This makes it become a good penicillinase, but a poor cephalosporinase due to slow acylation. The mutation of this will lead to the enzyme being inactivated, making the drug resistance not work efficiently. | ||
The research of this protein is very significant because it has a direct clinical application. | The research of this protein is very significant because it has a direct clinical application. | ||
| Line 24: | Line 25: | ||
== Other Important Features == | == Other Important Features == | ||
| - | + | <scene name='88/880343/Lys73/1'>Lys73</scene> is another very important amino acid of this CTX-M Beta-Lactamase. Lys73 interacts with the ligand through hydrogen bonds. It is used to lower the pka value of the hydroxyl group. | |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 21:40, 18 April 2021
CTX-M Beta-Lactamase
CTX-M Beta Lactamase is a class a enzyme. This enzyme creates drug resistance to ampicillin and cefotaxime through a two step process: deacylation and acylation.
| |||||||||||
